Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lisziewicz

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Antiviral Therapy|March 21, 2000
Hydroxyurea: mechanisms of HIV-1 inhibitionF Lori, J Lisziewicz
JAMA|December 26, 2001
Structured treatment interruptions for the management of HIV infectionF Lori, J Lisziewicz
Journal of Biological Regulators and Homeostatic Agents|April 14, 2000
Role of immune modulation in primary HIV infectionF Lori, J Lisziewicz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2000
Rationale for the use of hydroxyurea as an anti-human immunodeficiency virus drugF Lori, J Lisziewicz
Journal of Biological Regulators and Homeostatic Agents|November 24, 1999
Mechanisms of human immunodeficiency virus type 1 inhibition by hydroxyureaF Lori, J Lisziewicz
Antiviral Therapy|July 19, 2005
Hydroxyurea: overview of clinical data and antiretroviral and immunomodulatory effectsF Lori, J Lisziewicz
Antiviral Therapy|March 21, 2000
Cellular factors: targets for the treatment of HIV infectionF Lori, J Lisziewicz
Journal of Neurochemistry|May 1, 1989
Calcium uptake and protein phosphorylation in myenteric neurons, like the release of vasoactive intestinal polypeptide and acetylcholine, are frequency dependentD V Agoston, J Lisziewicz
Drugs|January 29, 2000
New uses for old drugs in HIV infection: the role of hydroxyurea, cyclosporin and thalidomideE Ravot, J Lisziewicz, F Lori
Current Drug Targets. Infectious Disorders|May 29, 2003
Immunological approaches for HIV therapyF Lori, L M Kelly, J Lisziewicz
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Antiviral Therapy|March 21, 2000
Hydroxyurea: mechanisms of HIV-1 inhibitionF Lori, J Lisziewicz
JAMA|December 26, 2001
Structured treatment interruptions for the management of HIV infectionF Lori, J Lisziewicz
Journal of Biological Regulators and Homeostatic Agents|April 14, 2000
Role of immune modulation in primary HIV infectionF Lori, J Lisziewicz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2000
Rationale for the use of hydroxyurea as an anti-human immunodeficiency virus drugF Lori, J Lisziewicz
Journal of Biological Regulators and Homeostatic Agents|November 24, 1999
Mechanisms of human immunodeficiency virus type 1 inhibition by hydroxyureaF Lori, J Lisziewicz
Antiviral Therapy|July 19, 2005
Hydroxyurea: overview of clinical data and antiretroviral and immunomodulatory effectsF Lori, J Lisziewicz
Antiviral Therapy|March 21, 2000
Cellular factors: targets for the treatment of HIV infectionF Lori, J Lisziewicz
Journal of Neurochemistry|May 1, 1989
Calcium uptake and protein phosphorylation in myenteric neurons, like the release of vasoactive intestinal polypeptide and acetylcholine, are frequency dependentD V Agoston, J Lisziewicz
Drugs|January 29, 2000
New uses for old drugs in HIV infection: the role of hydroxyurea, cyclosporin and thalidomideE Ravot, J Lisziewicz, F Lori
Current Drug Targets. Infectious Disorders|May 29, 2003
Immunological approaches for HIV therapyF Lori, L M Kelly, J Lisziewicz
Pageof 6